Alpha-synuclein overexpression can drive microbiome dysbiosis in mice

Timothy R. Sampson,Zachary D Wallen,Woong-Jai Won,David G. Standaert,Haydeh Payami,Ashley S. Harms

DOI: https://doi.org/10.1101/2024.02.01.578464

2024-02-01

Abstract:Growing evidence indicates that persons living with Parkinson disease (PD), have a unique composition of indigenous gut microbes. Given the long prodromal or pre-diagnosed period, longitudinal studies of the human and rodent gut microbiome prior to symptomatic onset and for the duration of the disease period are currently lacking. PD is characterized in part by accumulation of the protein α-synuclein (α-syn) into insoluble aggregates, in both the central and enteric nervous systems. As such, a number of experimental rodent and non-human primate models of α-syn overexpression recapitulate some of hallmark pathophysiologies of PD. These animal models provide an opportunity to assess how the gut microbiome changes with age under disease relevant conditions. Here, we used a transgenic mouse strain, the Thy1-hSYN “line 61” mice which over express wild-type human α-syn to test how the gut microbiome composition responds in this model of PD pathology during aging. Using shotgun metagenomics, we find significant, age and genotype dependent bacterial taxa that become altered over age. We reveal that α-syn overexpression can drive alterations to the gut microbiome composition and suggest that it limits the expansion of diversity through age. Given emerging data on potential contributions of the gut microbiome to PD pathologies, our data provide an experimental foundation to understand how the PD-associated microbiome may arise as a trigger or co-pathology to disease.

Microbiology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: whether over - expression of α - synuclein (α - syn) will lead to dysbiosis of the gut microbiota in mice, and how this dysbiosis develops as the mice age. Specifically, the researchers want to verify three main objectives:

1. **Determine whether α - syn over - expression will affect the composition of the gut microbiota in mice**: By comparing the differences in the gut microbiota between transgenic (TG) mice and non - transgenic (NTG) control mice at different time points, the impact of α - syn over - expression on the gut microbiota is evaluated.

2. **Determine whether this dysbiosis exists from birth or develops as the mice age**: Through longitudinal sampling of TG and NTG mice from 1 month to 12 months, the researchers hope to understand when the changes in the gut microbiota caused by α - syn over - expression begin to occur.

3. **Identify the specific microorganisms that may cause this dysbiosis**: By analyzing the microbial community structure at different time points, especially those microbial species that are significantly reduced or increased in α - syn over - expressing mice, to determine which specific microorganisms may be involved in this process.

Through these research objectives, the authors hope to reveal how α - syn over - expression affects the gut microbiota and explore whether these changes are related to the development of Parkinson's disease (PD). This study not only helps to understand the role of α - syn in PD pathology, but may also provide new clues for the early diagnosis and treatment of PD.